TERT promoter mutation positive oral cavity carcinomas, a clinically and genetically distinct subgroup of head and neck squamous cell carcinomas

Abstract

AbstractBackgroundsThe importance of TERT promoter (pTERT) mutation of oral cavity squamous cell carcinoma (OCSCC) with clinical features and genetic alterations are not well recognized.MethodsWe retrospectively analyzed genetic data from multiple databases, including 260 cases from the C‐CAT database, 407 cases from the MSK‐MetTropism database, and 40 OCSCC datasets from in‐house clinical samples.ResultsFrom C‐CAT database, TP53 (66%), CDKN2A (51%), and pTERT (29%) were the most frequent mutations observed. pTERT mutations were more prevalent in OCSCC (63%), younger individuals, and women (46%), with lower rates of alcohol abuse and smoking and co‐mutated with TP53, HRAS, and CASP8. MSK‐MetTroposim data validated with the enrichment of pTERT mutations in OCSCC, among women and Asian individuals. In‐house datasets OCSCC with pTERT mutation (50%) characterized by fewer recurrent neck metastases.ConclusionThe study suggests that OCSCC with pTERT mutation represents a distinct subgroup with unique clinical and genetic characteristics.